[Experience at Sheba Hospital in oncogenetic counseling and genetic testing of women with a high risk for breast and ovarian cancer].

Livia Theodor, Eitan Friedman(University of Pennsylvania), Irit Friedman(Sheba Medical Center), Yechezkel Gh, Gak E, Gilad Ben‐Baruch(Sheba Medical Center), Bar-Sade Rb, Anna Kruglikova(Sheba Medical Center), Ronit Shiri‐Sverdlov(Maastricht University), S Risel(Sheba Medical Center), Papa Mz, Boleslaw Goldman(BG Group (United Kingdom))
PubMed
April 15, 1998
Cited by 1

Related Papers

The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management
|Cells|2020|538
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer
|JAMA|2015|513
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†
|Hepatology|2008|467
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
Mutational spectrum in a worldwide study of 29,700 families with<i>BRCA1</i>or<i>BRCA2</i>mutations
|Human Mutation|2018|319